The Academy of Immuno-Oncology was established by SITC to honor individuals who have launched the field of cancer immunotherapy into the breakthrough cancer treatment it is today and bring together the brightest minds in the field to continue to advance SITC, the field, and the next generation of immuno-oncologists.
Annually, SITC conducts an open call for nominations and inducts a new class of Fellows into the Academy of Immuno-Oncology, one of the society’s most prestigious honors. (Actively serving nomination committee members or Board members are not eligible for nomination.) Fellows of the Academy of Immuno-Oncology bear the designation “FAIO.”
Nominations for 2022 are now closed, the Class of 2022 will be announced this summer.
2021 SITC Fellow of the Academy of Immuno-Oncology Recipients:
Watch the inaugural class discuss their career and what their induction in to the FAIO means to them.
|
|
|
|
|
James P. Allison, PhD The University of Texas MD Anderson Cancer Center Watch Interview
|
Lieping Chen, MD, PhD Yale School of Medicine Watch Interview
|
Zelig Eshhar, PhD Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center |
Gordon J. Freeman, PhD Dana-Farber Cancer Institute Watch Interview
|
Philip D. Greenberg, MD Fred Hutchinson Cancer Research Center Watch Interview
|
|
|
|
|
|
Tasuku Honjo, MD, PhD Kyoto University Graduate School of Medicine Watch Interview
|
Elizabeth M. Jaffee, MD Sidney Kimmel Cancer Center, Johns Hopkins University Watch Interview
|
Carl H. June, MD University of Pennsylvania Watch Interview
|
Alan J. Korman, PhD Vir Biotechnology Watch Interview
|
Margaret L. Kripke, PhD The University of Texas MD Anderson Cancer Center Watch Interview
|
|
|
|
|
|
Ronald Levy, MD Stanford University Watch Interview
|
Steven A. Rosenberg, MD, PhD National Cancer Institute/National Institutes of Health Watch Interview
|
Robert D. Schreiber, PhD Washington University School of Medicine Watch Interview
|
Arlene H. Sharpe, MD, PhD Harvard Medical School Watch Interview
|
Thomas A. Waldmann, MD National Cancer Institute/National Institutes of Health – Honored posthumously
|